Global law firm Freshfields has advised Merck KGaA, a leading science and technology company, on the financing of the purchase price for the proposed acquisition of U.S. life sciences company Bio-Techne Corporation.

Bio-Techne is a Minneapolis-based global provider of life science tools, analytical technologies, and consumables. The acquisition would deliver on Merck’s growth agenda by expanding its presence in high-growth, next-generation life sciences markets and further strengthening its position as a leader along the full life science value chain.

The Freshfields team was led by Partner Frank Laudenklos and Principal Associate Dennis Chinnow (both Finance, Frankfurt).

They were supported by a team including Associate Beatrice Zobel (Finance), Partner Sebastian Röger and Principal Associate Sebastian Jung (both Tax, all Frankfurt), Partner Kyle Lakin and Associates Nicholas Mack and Sydney Hallisey (all Finance), Partner Sarah Katz and Senior Associate Courtney Canning (both Tax, all New York).